Literature DB >> 22001778

Acute necrotizing eosinophilic myocarditis presenting as ST-elevation myocardial infarction: a case report.

Andres Enriquez1, Pablo Castro, Luigi Gabrielli, Sandra Braun, Hugo Verdejo, Samuel Cordova, Vania Van der linde Rosemberg.   

Abstract

Eosinophilic myocarditis (EM) is a rare disease. The spectrum of clinical presentation is wide and it is often fatal if left untreated. We report a case of eosinophilic myocarditis manifesting as ST-elevation myocardial infarction (STEMI) with cardiogenic shock treated successfully with steroids. This diagnosis should always be considered in patients with an acute coronary syndrome and normal coronary arteries, especially in the presence of a history of allergies, asthma or peripheral eosinophilia.
Copyright © 2011 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001778     DOI: 10.1016/j.cjca.2011.07.618

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  4 in total

Review 1.  A case report of eosinophilic myocarditis and a review of the relevant literature.

Authors:  Haiying Li; Zhenyu Dai; Binqiao Wang; Weijian Huang
Journal:  BMC Cardiovasc Disord       Date:  2015-02-26       Impact factor: 2.298

2.  A Pitfall in the Diagnosis of Eosinophilic Myocarditis in a Patient who Received Steroid Therapy.

Authors:  Yusuke Watanabe; Hiroshi Wada; Kenichi Sakakura; Hideo Fujita; Shin-Ichi Momomura
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

3.  Idiopathic hypereosinophilic syndrome presenting with multiple organ damage: A case report.

Authors:  Peng Wu; Yuanguo Chen; Haibo Zhang; Chen Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

4.  Hypereosinophilic Syndrome Complicated by Eosinophilic Myocarditis With Dramatic Response to Steroid.

Authors:  Mazin Khalid; Vijay Gayam; Sumit Dahal; Ebad Ur Rahman; Kamal Fadllala; Jaspreet Kaler; Mowyad Khalid; Alix Dufresne
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.